Illumina, Inc. introduced three early-access capabilities on its BioInsight Platform that help researchers move faster from sequencing data to discovery. BioInsight Platform Workflow Orchestrator ...

Illumina has introduced three early-access software capabilities on its BioInsight Platform designed to automate informatics ...

Illumina, Inc. (NASDAQ: ILMN) today introduced three early-access capabilities on its BioInsight Platform that help ...

Illumina on October 14, 2026 debuted the Illumina BioInsight Platform, which the company describes as its first unified ...

This video analyzes Illumina's effort to build an AI-driven data moat through its Billion Cell Atlas and the impact this ...

Here are 10 “Up & Comers” spatial biology companies that are not large enough to be ranked as public or private companies, ...

"Variant effect prediction tools, such as SpliceAI2, are among the key areas of focus for the BioInsight AI Lab," said Rami Mehio, senior vice president and general manager of BioInsight at Illumina. ...

Illumina, Inc. introduced SpliceAI2, a new genomic AI model designed to address one of the central challenges in genomics: understanding the functional consequences of genetic variation. SpliceAI2 ...

Indian-origin scientist Shankar Balasubramanian has won the 2026 Wolf Prize in Chemistry for his contribution to next-generation DNA sequencing. Discover his journey and the breakthrough that ...

PureWow editors select every item that appears on this page, and some items may be gifted to us. Additionally, PureWow may earn compensation through affiliate links within the story. All prices are ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Illumina became a genomics juggernaut by developing machines that could read large ...